LifeVantage (NASDAQ:LFVN – Get Rating) and Pharming Group (OTCMKTS:PHGUF – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, analyst recommendations, earnings, valuation, dividends and institutional ownership.
Earnings & Valuation
This table compares LifeVantage and Pharming Group’s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
LifeVantage | $206.36 million | 0.21 | $3.12 million | ($0.05) | -68.00 |
Pharming Group | $198.87 million | 3.17 | $16.00 million | $0.04 | 24.13 |
Pharming Group has lower revenue, but higher earnings than LifeVantage. LifeVantage is trading at a lower price-to-earnings ratio than Pharming Group, indicating that it is currently the more affordable of the two stocks.
Profitability
Net Margins | Return on Equity | Return on Assets | |
LifeVantage | -0.35% | 5.21% | 2.42% |
Pharming Group | 14.90% | 15.52% | 7.77% |
Institutional & Insider Ownership
29.7% of LifeVantage shares are held by institutional investors. 6.8% of LifeVantage shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Volatility and Risk
LifeVantage has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, Pharming Group has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500.
Analyst Recommendations
This is a summary of current ratings and target prices for LifeVantage and Pharming Group, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
LifeVantage | 0 | 0 | 0 | 0 | N/A |
Pharming Group | 0 | 0 | 0 | 0 | N/A |
Summary
Pharming Group beats LifeVantage on 7 of the 11 factors compared between the two stocks.
About LifeVantage
LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region, and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs. The company was founded in June 1988 and is headquartered in Sandy, UT.
About Pharming Group
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.